To validate our findings that carnosol treatment ameliorated NASH by suppressing NLRP3 inflammasome activation, we assessed the activation of the NLRP3 inflammasome using a NASH model. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.